EVT — Evotec SE Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual cashflow statement for Evotec SE, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6.25	216	-176	-83.9	-196
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	23.9	-165	211	50.2	105
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-48.9	-0.576	86.8	-22.8	7.88
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	44.7	122	206	36.4	18.2
Capital Expenditures	-99.1	-119	-181	-216	-132
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-56	-125	-231	203	61
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-155	-244	-413	-13.3	-71.2
Financing Cash Flow Items	—	—	-5.73	-12.9	-9.72
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	246	398	-58.1	72	-161
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	146	277	-284	95.8	-205